trending Market Intelligence /marketintelligence/en/news-insights/trending/y2ylmul5bkj-x6mt6vncwq2 content esgSubNav
In This List

Five Prime Therapeutics CFO resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Five Prime Therapeutics CFO resigns

Five Prime Therapeutics Inc. said its CFO and senior vice president, Marc Belsky, resigned to pursue another opportunity.

Belsky will continue in his current role until April 6.

The South San Francisco, Calif.-based cancer drug developer plans to start a search for a new CFO immediately.